Absolute Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$288K Sell
240
-13
-5% -$13.3K 0.07% 142
2026
Q1
$233K Buy
253
+8
+3% +$8.11K 0.08% 137
2025
Q4
$263K Buy
+245
New +$234K 0.1% 114
2025
Q1
Sell
-307
Closed -$238K 124
2024
Q4
$238K Buy
307
+31
+11% +$25.7K 0.13% 113
2024
Q3
$245K Sell
276
-5
-2% -$4.5K 0.15% 102
2024
Q2
$254K Buy
+281
New +$225K 0.15% 96
2022
Q4
Sell
-72
Closed -$23.6K 333
2022
Q3
$23.6K Buy
+72
New +$22.8K 0.03% 120
2022
Q1
Sell
-2
Closed -$552 306
2021
Q4
$552 Buy
+2
New +$507 ﹤0.01% 491

Other funds holding LLY

Absolute Capital Management's LLY Position: Q2 2026 in Review

Absolute Capital Management reduced its Eli Lilly (LLY) stake by 5.1% in Q2 2026, selling an estimated $13.3K and leaving 240 shares worth $288K. The position accounts for 0.07% of the portfolio, ranked #142.

Absolute Capital Management first reported a position in LLY in Q4 2021 and has held it in 8 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Absolute Capital Management held 240 shares of Eli Lilly worth $288K as of Q2 2026.
  • Absolute Capital Management sold 13 Eli Lilly shares in Q2 2026, an estimated $13.3K.
  • Eli Lilly made up 0.07% of Absolute Capital Management's portfolio in Q2 2026, its #142 holding.
  • Absolute Capital Management first reported a position in Eli Lilly in Q4 2021 and has held it in 8 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Absolute Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.